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Abstract
C27H21N5O, triclinic, P1¯ (no. 2), a= 8.1464(7) Å,
b= 10.3861(8) Å, c= 13.2507(9) Å, α= 84.898(6)°,
β= 89.413(6)°, γ= 80.351(7)°, V = 1100.88(15) Å3, Z= 2,
Rgt(F)=0.0648, wRref(F2)=0.1726, T= 296(2) K.
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Table 1: Data collection and handling.
Crystal: Colourless block
Size: 0.31×0.18×0.08 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.08 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.8°,>99%
N(hkl)measured, N(hkl)unique, Rint: 8540, 5164, 0.035
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2801
N(param)refined: 300
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX/ORTEP [4]
Table 1 contains crystallographic data and Table 2 contains
the list of the atoms including atomic coordinates and dis-
placement parameters.
Source of material
The title compound was synthesized from the reaction of
equimolar quantities of 3-(5-methyl-1-phenyl-1H-1,2,3-triazol-
4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde and acetophe-
none in ethanol in presence of sodium hydroxide (10%)
for 2 h at room temperature. The crude product was col-
lected by filtration, washed with water and recrystallized
from dimethylformamide to give colourless crystals (90%).
Experimental details
All hydrogen atoms were placed in calculated positions using
a riding model. Methyl C—H bonds were fixed at 0.96 Å, with
U(H) = 1.5 Ueq(C). C—H distances for sp2 hybridized groups
were set to 0.93 Å and their U iso(H) set to 1.2 times the Ueq(C).
The high R1 value for all reflections is attributable to the
weakness of data, particularly above 0.9 Å resolution.
Comment
Chalcones are an important class of compounds found in vari-
ous natural products [5]. The synthetic methods for chalcone-
containing compounds are simple, efficient, convenient, and
high yielding [6]. Synthetic and natural chalcones show
various interesting medicinal activities [7, 8]. They act as
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
C1 0.6089(3) 0.1784(2) −0.2761(2) 0.0612(7)
C2 0.6412(4) 0.3049(2) −0.2969(2) 0.0660(7)
H2 0.660160 0.353945 −0.244058 0.079*
C3 0.6451(4) 0.3581(3) −0.3960(2) 0.0796(9)
H3 0.667613 0.442744 −0.409638 0.096*
C4 0.6162(4) 0.2875(3) −0.4738(2) 0.0856(9)
H4 0.616829 0.324622 −0.540299 0.103*
C5 0.5865(4) 0.1624(3) −0.4542(2) 0.0895(10)
H5 0.569364 0.113822 −0.507679 0.107*
C6 0.5816(4) 0.1077(3) −0.3566(2) 0.0807(9)
H6 0.559874 0.022691 −0.344140 0.097*
C7 0.6034(4) 0.1137(2) −0.1708(2) 0.0652(7)
C8 0.5277(3) 0.1846(2) −0.08732(19) 0.0585(7)
H8 0.545470 0.142525 −0.022470 0.070*
C9 0.4355(3) 0.3039(2) −0.09493(17) 0.0501(6)
H9 0.426345 0.349818 −0.158716 0.060*
C10 0.3489(3) 0.3679(2) −0.01301(16) 0.0467(6)
C11 0.3147(3) 0.3126(2) 0.08149(17) 0.0511(6)
H11 0.346655 0.225166 0.105600 0.061*
C12 0.2738(3) 0.5013(2) −0.01143(16) 0.0463(6)
C13 0.1591(3) 0.3941(2) 0.23171(17) 0.0495(6)
C14 0.2429(4) 0.3062(2) 0.30552(19) 0.0649(7)
H14 0.345146 0.256278 0.291775 0.078*
C15 0.1718(4) 0.2936(3) 0.4003(2) 0.0737(8)
H15 0.226417 0.233793 0.450413 0.088*
C16 0.0224(4) 0.3678(3) 0.42142(19) 0.0672(8)
H16 −0.023686 0.358802 0.485630 0.081*
C17 −0.0593(4) 0.4558(2) 0.3475(2) 0.0657(7)
H17 −0.161269 0.505861 0.361536 0.079*
C18 0.0098(3) 0.4700(2) 0.25212(18) 0.0562(6)
H18 −0.044530 0.530426 0.202291 0.067*
C19 0.2722(3) 0.6090(2) −0.09084(16) 0.0456(6)
C20 0.1836(3) 0.7342(2) −0.09528(16) 0.0464(6)
C21 0.0581(3) 0.8011(2) −0.02716(19) 0.0603(7)
H21A 0.112761 0.844419 0.020424 0.091*
H21B 0.000916 0.737577 0.008784 0.091*
H21C −0.020517 0.864517 −0.066555 0.091*
C22 0.1777(3) 0.9212(2) −0.23063(17) 0.0498(6)
C23 0.1120(4) 0.9394(2) −0.3261(2) 0.0761(9)
H23 0.102721 0.867816 −0.361756 0.091*
C24 0.0597(5) 1.0649(3) −0.3689(2) 0.0902(11)
H24 0.014412 1.077883 −0.433927 0.108*
C25 0.0733(4) 1.1702(3) −0.3176(2) 0.0717(8)
H25 0.037417 1.254620 −0.347327 0.086*
C26 0.1398(4) 1.1517(2) −0.2224(2) 0.0722(8)
H26 0.149137 1.223692 −0.187122 0.087*
C27 0.1931(4) 1.0268(2) −0.1782(2) 0.0653(7)
H27 0.239114 1.014022 −0.113464 0.078*
N1 0.2275(3) 0.40624(17) 0.13255(13) 0.0491(5)
N2 0.1999(3) 0.52498(16) 0.07659(14) 0.0511(5)
N3 0.3666(3) 0.59442(17) −0.17605(14) 0.0529(5)
N4 0.3412(3) 0.70498(18) −0.23374(14) 0.0546(5)
N5 0.2308(3) 0.79058(17) −0.18469(13) 0.0487(5)
O1 0.6609(3) −0.00381(18) −0.15491(17) 0.1037(8)
antibacterial, antiviral, antiulcer, antihelmintic, antiproto-
zoal, antioxidative, and insecticidal agents [9–13].
In the crystal structure, the asymmetric unit consists of
one molecule (see the figure). The molecule comprises five
ring systems, namely: A, phenyl (C1—C6); B, pyrazolyl (C10—
C12,N1,N2); C, a second phenyl (C13—C18); D, triazolyl (C19—
C21,N3—N5) and E, a third phenyl (C22—C27) group. The core
of the molecule consists of rings B and D, which are almost
coplanar with a twist angle of 10.35(12)°. The phenyl groups
deviate from the core plane with interplanar angles A/B, B/C
and D/E of 42.24(7)°, 33.54(11)° and 55.72(7)°, respectively.
The molecule displays an intramolecular C—H· · ·N con-
tact with a C21· · ·N2 distance of 3.109(3) Å. An intermolecu-
lar C—H· · ·O contact with a C11· · ·O1 distance of 3.241(3) Å is
also observed. Some related structures show similar features
[14, 15].
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